Search

everythinglearnresearchcommunity

for

Search:↓

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Spironolactone may be effective for acne and other skin conditions and could be used more in treatment.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

Hormone levels studied are not linked to PCOS.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

In 1981, the punch graft technique was the main method for hair transplantation, and medical treatments for baldness were not very effective.

Androgens affect skin conditions like acne and hirsutism, treatable with hormone therapy and other methods.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Lasers are effective for hair removal, especially for conditions like excessive hair growth.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Metformin is effective for various skin disorders but may cause skin side effects.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

Maxillariinae orchids contain 62 compounds with potential health benefits, including treating skin conditions and diseases like cancer and diabetes.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.